6693 articles
New research reveals extreme endurance running can make red blood cells less flexible and more prone to breakdown, potentially affecting oxygen delivery.
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
Completed study tested regenerative cardiac therapy in 105 heart attack patients, comparing stem cell treatment to placebo controls.
Clinical trial tested whether bone marrow stem cells could improve heart function beyond standard bypass surgery alone.
Pfizer's oral JAK inhibitor demonstrated efficacy comparable to adalimumab for treating moderate to severe rheumatoid arthritis.
New research reveals how RA affects muscle biomechanics within 6 months of symptom onset, offering insights for early intervention.
Large Hong Kong registry study tracked how well patients stayed on newer JAK inhibitors versus traditional TNF blockers for RA treatment.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
